Glial fibrillary acidic protein is a body fluid biomarker for glial pathology in human disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Glial fibrillary acidic protein is a body fluid biomarker for glial pathology in human disease

Published:2015-03 Issue: Volume:1600 Page:17-31
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Petzold Axel^ORCID

Funder

University College London Comprehensive Biomedical Research Centre

Moorfields Biomedical Research Centre

Dutch MS Research Foundation (grants 09-687 MS and 09-358 d MS)

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference182 articles.

1. Caspase-3 activation in astrocytes following postnatal excitotoxic damage correlates with cytoskeletal remodeling but not with cell death or proliferation;Acarin;Glia,2007

2. Diagnostic value of serum level of GFAP, NF-H and NSE compared with clinical findings in severity assessment of human traumatic spinal cord injury;Ahadi;Spine (Phila Pa 1976),2014

3. Quantification of glial fibrillary acidic protein (GFAP) in human- body fluids by means of elisa employing a monoclonal-antibody;Albrechtsen;J. Neuroimmunol.,1985

4. Glial fibrillary acidic protein in amniotic fluids from pregnancies with fetal neural-tube defects;Albrechtsen;Prenatal Diagn.,1984

5. Enzyme-linked immunosor-bent assay for the human glial fibrillary acidic protein using a mouse monoclonal antibody;Albrechtsen;J. Neurochem.,1985

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GFAP and UCHL1 in Non-traumatic SAH: The Story thus Far. A Systematic Review of the Literature;CNS & Neurological Disorders - Drug Targets;2024-11

2. Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: an update of the literature;Expert Review of Neurotherapeutics;2024-09-04

3. The Evaluation of Clinical Applications for the Detection of the Alzheimer’s Disease Biomarker GFAP;Critical Reviews in Analytical Chemistry;2024-08-23

4. Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis;Frontiers in Immunology;2024-08-19

5. Evaluation of GFAP, S100B, and UCHL-1 Levels in Children With Refractory Epilepsy;Journal of Child Neurology;2024-08-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3